Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02761837 · ClinicalTrials.gov registry record · NA

The Breathe Well Program for Adults With Asthma

A NA study of Asthma, sponsored by National Jewish Health.

Completed
Registry status
NA
Development phase
14,978
Enrollment target
1
Study location

NCT02761837 is a NA study of Asthma that has completed, run by National Jewish Health. The registered enrollment target is 14,978 participants, above the 1,523-participant average among 374 other Asthma trials with a reported enrollment target (883% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02761837, a NA study of Asthma, has completed, sponsored by National Jewish Health.

COMPLETED
Registry status
NA
Development phase
14,978 participants
Enrollment target
1
Study location

Study Summary

The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.

Conditions Studied

Asthma

Interventions

  • BEHAVIORAL Email
  • BEHAVIORAL IVR call/text

Study Locations (1)

Colorado

  • Kaiser Permanente of Colorado - Denver

Trial Details

FieldValue
Enrollment Target 14,978 participants
Start Date 2016-10
Est. Completion 2023-06
Phase NA

Sponsor

National Jewish Health

83 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02761837

The ClinicalTrials.gov registry entry for NCT02761837 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14,978 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,523-participant average among 374 other Asthma trials with a reported enrollment target (883% higher). The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Email is the first listed.

NCT02761837 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02761837 about?

NCT02761837 is a clinical study titled "The Breathe Well Program for Adults With Asthma". The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.

What is the current status of trial NCT02761837?

This trial is currently completed. It is a NA study. The enrollment target is 14,978 participants. The study started on 2016-10. Estimated completion is 2023-06.

What conditions does trial NCT02761837 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT02761837?

The interventions under investigation include: Email (BEHAVIORAL), IVR call/text (BEHAVIORAL).

Who is sponsoring clinical trial NCT02761837?

This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02761837 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.